
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
Jianwen Sheng, Shanjin Zhang, Lule Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Jianwen Sheng, Shanjin Zhang, Lule Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Showing 23 citing articles:
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 35
Chandni Pathak, Uma D. Kabra
Bioorganic Chemistry (2024) Vol. 144, pp. 107152-107152
Closed Access | Times Cited: 35
Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
Gajendra Kumar, G. Pratap, D Poornima, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100154-100154
Open Access | Times Cited: 19
Gajendra Kumar, G. Pratap, D Poornima, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100154-100154
Open Access | Times Cited: 19
From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease
Kunal Bhattacharya, Atanu Bhattacharjee, Manodeep Chakraborty, et al.
Journal of Computational Chemistry (2025) Vol. 46, Iss. 2
Closed Access
Kunal Bhattacharya, Atanu Bhattacharjee, Manodeep Chakraborty, et al.
Journal of Computational Chemistry (2025) Vol. 46, Iss. 2
Closed Access
Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease
Shilpa Kumari, Kajal Bagri, Rahul Deshmukh
Inflammopharmacology (2025)
Closed Access
Shilpa Kumari, Kajal Bagri, Rahul Deshmukh
Inflammopharmacology (2025)
Closed Access
Exploring Brain Imaging and Genetic Risk Factors in Different Progression States of Alzheimer’s Disease Through OSnetNMF-Based Methods
Min Gao, Wei Kong, Kun Liu, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Min Gao, Wei Kong, Kun Liu, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access
Mitochondrial Complex I, a Possible Sensible Site of cAMP Pathway in Aging
Anna Signorile, Domenico De Rasmo
Antioxidants (2023) Vol. 12, Iss. 2, pp. 221-221
Open Access | Times Cited: 12
Anna Signorile, Domenico De Rasmo
Antioxidants (2023) Vol. 12, Iss. 2, pp. 221-221
Open Access | Times Cited: 12
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1013-1013
Open Access | Times Cited: 10
Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1013-1013
Open Access | Times Cited: 10
Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 580-580
Open Access | Times Cited: 8
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 580-580
Open Access | Times Cited: 8
Disease-Modifying Effects of Non-Invasive Electroceuticals on β-Amyloid Plaques and Tau Tangles for Alzheimer’s Disease
Junsoo Bok, Juchan Ha, Bum Ju Ahn, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 679-679
Open Access | Times Cited: 10
Junsoo Bok, Juchan Ha, Bum Ju Ahn, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 679-679
Open Access | Times Cited: 10
Augmented Doubly Robust Post-Imputation Inference for Proteomic data
Haeun Moon, Jin‐Hong Du, Jing Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Haeun Moon, Jin‐Hong Du, Jing Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking
Bruna R. Kouba, Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 893-893
Open Access | Times Cited: 1
Bruna R. Kouba, Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 893-893
Open Access | Times Cited: 1
PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
Phool Chandra, Vikas Sharma
INDIAN DRUGS (2024) Vol. 61, Iss. 07, pp. 7-22
Closed Access | Times Cited: 1
Phool Chandra, Vikas Sharma
INDIAN DRUGS (2024) Vol. 61, Iss. 07, pp. 7-22
Closed Access | Times Cited: 1
Resveratrol alleviates amyloid β‐induced neuronal apoptosis, inflammation, and oxidative and endoplasmic reticulum stress by circ_0050263/miR ‐361‐3p/PDE4A axis during Alzheimer's disease
Yanchun Zhang, Deqiang Chen, Rui Tian, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 5, pp. 1121-1132
Closed Access | Times Cited: 4
Yanchun Zhang, Deqiang Chen, Rui Tian, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 5, pp. 1121-1132
Closed Access | Times Cited: 4
Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by using Network Pharmacology and Molecular Docking
Glorister A. Altê, Ana Lúcia S. Rodrigues
(2023)
Open Access | Times Cited: 3
Glorister A. Altê, Ana Lúcia S. Rodrigues
(2023)
Open Access | Times Cited: 3
Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery
Vaishali M. Patil, Neeraj Masand, Vertika Gautam, et al.
(2023), pp. 285-319
Closed Access | Times Cited: 2
Vaishali M. Patil, Neeraj Masand, Vertika Gautam, et al.
(2023), pp. 285-319
Closed Access | Times Cited: 2
Sildenafil Reverses the Neuropathological Alzheimer’s Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation
Daniela Giraldo-Berrio, Marlene Jiménez-Del-Río, Carlos Vélez-Pardo
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 2, pp. 639-656
Closed Access
Daniela Giraldo-Berrio, Marlene Jiménez-Del-Río, Carlos Vélez-Pardo
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 2, pp. 639-656
Closed Access
Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer’s Disease via Fyn Tyrosine Kinase Inhibition
Shreya Satyanarayan Bhat, Spoorthi R Kulkarni, Akshay Uttarkar, et al.
Molecular Biotechnology (2024)
Closed Access
Shreya Satyanarayan Bhat, Spoorthi R Kulkarni, Akshay Uttarkar, et al.
Molecular Biotechnology (2024)
Closed Access
Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases
Anurag Thapliyal, Shweta Shweta, Shashank Kumar Maurya
(2024), pp. 365-416
Closed Access
Anurag Thapliyal, Shweta Shweta, Shashank Kumar Maurya
(2024), pp. 365-416
Closed Access
The Emerging Role of Phosphodiesterase 5 Inhibition in Neurological Disorders: The State of the Art
Clara Crescioli, Maria Paola Paronetto
Cells (2024) Vol. 13, Iss. 20, pp. 1720-1720
Open Access
Clara Crescioli, Maria Paola Paronetto
Cells (2024) Vol. 13, Iss. 20, pp. 1720-1720
Open Access
Identification of Salvianolic acid A as a potent inhibitor of PDEs to enhance proliferation of human neural stem cells
Ya-Lin Li, Jun Mao, Xiufen Tian, et al.
Journal of Molecular Structure (2024) Vol. 1324, pp. 140905-140905
Closed Access
Ya-Lin Li, Jun Mao, Xiufen Tian, et al.
Journal of Molecular Structure (2024) Vol. 1324, pp. 140905-140905
Closed Access
Vardenafil Long-Term Administration Improves Episodic Memory in Aging Female Mice
Harold Dadomo, Davidé Ponzi, Silvia Paterlini, et al.
Applied Sciences (2023) Vol. 13, Iss. 22, pp. 12470-12470
Open Access
Harold Dadomo, Davidé Ponzi, Silvia Paterlini, et al.
Applied Sciences (2023) Vol. 13, Iss. 22, pp. 12470-12470
Open Access